These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12944692)

  • 1. Serum biochemical markers in carcinoma breast.
    Seth LR; Kharb S; Kharb DP
    Indian J Med Sci; 2003 Aug; 57(8):350-4. PubMed ID: 12944692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
    Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
    Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of serum Ada, GGT and alp in carcinoma breast-a case control study for diagnostic and prognostic significance.
    Choudhari A; Desai P; Indumati V; Kadi S
    Indian J Med Sci; 2013; 67(5-6):123-9. PubMed ID: 24326764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.
    D'Alessandro R; Roselli M; Ferroni P; Mariotti S; Spila A; Aloe S; Carone MD; Abbolito MR; Carlini S; Perri P; Ricciotti A; Botti C; Conti F; Vici P; Chiappetta NR; Cognetti F; Buonomo O; Guadagni F
    Breast Cancer Res Treat; 2001 Jul; 68(1):9-19. PubMed ID: 11678313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms.
    Bilecova-Rabajdova M; Urban P; Gregova K; Varga J; Fialkovicová V; Kruzliak P; Marekova M
    Dis Markers; 2014; 2014():156034. PubMed ID: 24696529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between preoperative serum CA 15-3 and CEA levels and clinicopathological parameters in breast cancer.
    Moazzezy N; Farahany TZ; Oloomi M; Bouzari S
    Asian Pac J Cancer Prev; 2014; 15(4):1685-8. PubMed ID: 24641390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer.
    Kilic N; Yavuz Taslipinar M; Guney Y; Tekin E; Onuk E
    Ann Surg Oncol; 2014 Dec; 21(13):4139-43. PubMed ID: 24962940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic significance of serum cholinesterase and lactate dehydrogenase in breast cancer.
    Khan N; Tyagi SP; Salahuddin A
    Indian J Pathol Microbiol; 1991 Apr; 34(2):126-30. PubMed ID: 1752638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer.
    Bozkurt O; Berk V; Kaplan MA; Cetin B; Ozaslan E; Karaca H; Inanc M; Duran AO; Ozkan M
    Asian Pac J Cancer Prev; 2014; 15(6):2501-4. PubMed ID: 24761854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.
    Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ
    Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
    Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
    Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
    Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
    World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
    Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
    Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate dehydrogenase, catalase, and superoxide dismutase in tumor tissue of breast cancer patients in respect to mammographic findings.
    Radenkovic S; Milosevic Z; Konjevic G; Karadzic K; Rovcanin B; Buta M; Gopcevic K; Jurisic V
    Cell Biochem Biophys; 2013 Jun; 66(2):287-95. PubMed ID: 23197387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
    Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
    Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].
    Ruibal A; Garrido Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(3):180-3. PubMed ID: 16762272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum erbB-2 in ductal carcinoma in situ of the breast--a marker of microinvasion?
    Esteva-Lorenzo FJ; Paik S; Harris LN
    Acta Oncol; 1997; 36(6):651-2. PubMed ID: 9408158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.